Genprex, Inc. Shareholders' Equity
Genprex, Inc. (GNPX) had Shareholders' Equity of $14.80 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $14.80M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $16.93M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $7.96M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $767.81K.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $14.80M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $16.93M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $7.96M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $767.81K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.39M 10-Q · filed 2026-08-14 | $1.39M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $3.87M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $1.62M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $1.66M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $4.35M 10-Q · filed 2025-11-14 | $4.35M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $8.76M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $7.42M 10-K · filed 2026-03-30 | |
| 2023-09-30 | $12.31M 10-Q · filed 2024-11-13 | $12.31M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $12.05M 10-Q · filed 2024-11-13 | $12.05M 10-Q · filed 2023-08-21 |
| 2023-03-31 | $18.48M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $22.27M 10-K · filed 2025-04-01 | |
| 2022-09-30 | $27.49M 10-Q · filed 2023-11-14 | $27.49M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $32.41M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $37.02M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $41.28M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $45.17M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $47.68M 10-Q · filed 2022-11-14 | $47.68M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $50.42M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $30.92M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $22.98M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $24.51M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $23.94M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $3.02M 10-K · filed 2022-03-30 | |
| 2019-09-30 | $3.53M 10-Q · filed 2020-11-12 | $3.53M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $5.33M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $7.25M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $8.88M 10-K · filed 2021-03-26 | |
| 2018-09-30 | $10.48M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $12.59M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | -$41.91K 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $428.57K 10-K · filed 2020-03-30 | |
| 2017-09-30 | $871.52K 10-Q · filed 2017-12-05 | |
| 2016-12-31 | $1.62M 10-K · filed 2019-04-01 | |
| 2015-12-31 | $393.74K 10-K · filed 2018-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |